Arkolith/Insider Trading/TCRX/Form 4

Klencke Barbara

DirectorTScan Therapeutics, Inc. (TCRX) · full profile →Form 4 · filed Dec 18, 2023
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 14, 2023Buy(P)5K$5.08$25K30K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-071208) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML